Dr. Brian Saul Levitt, MD

Dr. Levitt practices at San Jose Gastroenterology, Medical Corp. in San Jose, California.

Dr. Levitt's NPI, 1235257759, was assigned on March 26, 2007. Dr. Levitt graduated from UMass Chan Medical School in 2001. Dr. Levitt holds California license A99206.

Dr. Levitt's primary practice is San Jose Gastroenterology, Medical Corp., at 2331 Montpelier Dr, San Jose, CA 95116 in Santa Clara County. The practice phone is (408) 347-9001.

Dr. Levitt's primary practice is San Jose Gastroenterology, Medical Corp. in San Jose, California. Dr. Levitt is also affiliated with Santa Clara Valley Medical Center. The medical group on file is San Jose Gastroenterology. Dmand AI also links Dr. Levitt to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levitt practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Levitt's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Levitt is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Levitt's licenses on file in 2 states: California and New York.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Levitt treats.

CMS data shows 1,103 Medicare services from Dr. Levitt across 11 procedure codes in 2024, for 317 Medicare patients. Medicare paid $88,074 for them.

CMS counts 317 Medicare patients who saw Dr. Levitt in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levitt's median patient age at 62, with 40% women.

In 2024, Dr. Levitt wrote 731 Medicare Part D claims for 342 patients. 76% of them were for generic drugs. CMS names the drug for 601 of them, across 11 drugs with 11 or more claims each, at $112,164 in total drug cost. In 2023, CMS named 514 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Levitt for performance year 2024, reported individually. Dr. Levitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levitt as offering telehealth. CMS counts 231 procedures of colonoscopy by Dr. Levitt, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Levitt, published from 2003 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Antiviral Agents, Hepatitis B, Chronic and Hepatitis C, Chronic. Dr. Levitt has published most often in J Viral Hepat. Dr. Levitt's most frequent co-authors are Huy Ngoc Trinh, MD, Huy Anh Nguyen, MD and Ruel Tan Garcia, MD.

CMS Open Payments shows 104 general payments to Dr. Levitt from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Gilead Sciences, Inc. paid the most, $1,979.

Dr. Levitt graduated from UMass Chan Medical School in 2001.

Dr. Levitt is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.